AGEN vs ZBH · P/E 1.6, rev $68.3M vs P/E 23, rev $8.23B
Agenus Inc (AGEN) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Agenus Inc (AGEN) is a biotechnology company listed on US.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported AGEN revenue for 2026-06-30 was $68.3M. Net income was $38.6M. AGEN currently screens at market cap $134.5M and trailing P/E 1.6.
Latest reported ZBH revenue for 2025-12-31 was $8.23B. Net income was $705.1M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
AGEN currently screens at market cap $134.5M and trailing P/E 1.6. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the AGEN and ZBH stock pages for the full models.
Not investment advice.